Update on infection prevention in the ICU
Filippo Medioli(Azienda Ospedaliero-Universitaria di Modena), Marianna Meschiari(Azienda Ospedaliero-Universitaria di Modena), Erica Franceschini(University of Modena and Reggio Emilia), Cristina Mussini(University of Modena and Reggio Emilia)
Cited by 5
Related Papers
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
|Clinical Infectious Diseases|2018|424
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
|CHEST Journal|2021|404